New Delhi: Drug firm Dr Reddy`s Laboratories today said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget`s disease of bone in the US market following approval from the US health regulator. The company has launched Zoledronic Acid injection (5 mg/ 100 mL) yesterday, following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), Dr Reddy`s Laboratories said in a statement. The product is generic version of Novartis AG`s Reclast injection in the same strength, it added.
Zapping brain with magnets may cure cocaine addiction
China briefs WHO on new bird flu